176 related articles for article (PubMed ID: 25988740)
1. Neutrophil to lymphocyte ratio and risk of a first episode of stroke in patients with atrial fibrillation: a cohort study.
Saliba W; Barnett-Griness O; Elias M; Rennert G
J Thromb Haemost; 2015 Nov; 13(11):1971-9. PubMed ID: 25988740
[TBL] [Abstract][Full Text] [Related]
2. The role of CHADS2 and CHA2 DS2 -VASc scores in the prediction of stroke in individuals without atrial fibrillation: a population-based study.
Saliba W; Gronich N; Barnett-Griness O; Rennert G
J Thromb Haemost; 2016 Jun; 14(6):1155-62. PubMed ID: 27037960
[TBL] [Abstract][Full Text] [Related]
3. The association between red cell distribution width and stroke in patients with atrial fibrillation.
Saliba W; Barnett-Griness O; Elias M; Rennert G
Am J Med; 2015 Feb; 128(2):192.e11-8. PubMed ID: 25447618
[TBL] [Abstract][Full Text] [Related]
4. Use of neutrophil-lymphocyte ratio for risk stratification and relationship with time in therapeutic range in patients with nonvalvular atrial fibrillation: A pilot study.
Cosansu K; Vatan MB; Gunduz H; Akdemir R
Clin Cardiol; 2018 Mar; 41(3):339-342. PubMed ID: 29569402
[TBL] [Abstract][Full Text] [Related]
5. Glycated hemoglobin and risk of first episode stroke in diabetic patients with atrial fibrillation: A cohort study.
Saliba W; Barnett-Griness O; Elias M; Rennert G
Heart Rhythm; 2015 May; 12(5):886-92. PubMed ID: 25614249
[TBL] [Abstract][Full Text] [Related]
6. Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
Lip GYH; Murphy RR; Sahiar F; Ingall TJ; Dhamane AD; Ferri M; Hlavacek P; Preib MT; Keshishian A; Russ C; Rosenblatt L; Yuce H; Deitelzweig S
JAMA Netw Open; 2022 Aug; 5(8):e2229333. PubMed ID: 36044214
[TBL] [Abstract][Full Text] [Related]
7. The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation.
Patti G; Sticchi A; Pasceri V; Ricci F; Renda G; Hamrefors V; Melander O; Sutton R; Engström G; De Caterina R; Fedorowski A
Diabetes Metab Res Rev; 2019 Jul; 35(5):e3145. PubMed ID: 30790434
[TBL] [Abstract][Full Text] [Related]
8. Association of CHA
Hjelholt TJ; Johnsen SP; Brynningsen PK; Pedersen AB
J Am Geriatr Soc; 2020 Aug; 68(8):1698-1705. PubMed ID: 32294240
[TBL] [Abstract][Full Text] [Related]
9. Refinement of ischemic stroke risk in patients with atrial fibrillation and CHA2 DS2 -VASc score of 1.
Huang D; Anguo L; Yue WS; Yin L; Tse HF; Siu CW
Pacing Clin Electrophysiol; 2014 Nov; 37(11):1442-7. PubMed ID: 25039724
[TBL] [Abstract][Full Text] [Related]
10. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
Saliba W; Rennert G
Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
[TBL] [Abstract][Full Text] [Related]
11. Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores.
Esteve-Pastor MA; Marín F; Bertomeu-Martinez V; Roldán-Rabadán I; Cequier-Fillat Á; Badimon L; Muñiz-García J; Valdés M; Anguita-Sánchez M;
Intern Med J; 2016 May; 46(5):583-9. PubMed ID: 26929032
[TBL] [Abstract][Full Text] [Related]
12. Augmented intelligence decision tool for stroke prediction combines factors from CHA
Horne BD; Jacobs V; May HT; Graves KG; Bunch TJ
J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1452-1461. PubMed ID: 31115939
[TBL] [Abstract][Full Text] [Related]
13. Burden of atrial fibrillation: a retrospective review of patients presenting to acute medical services.
Jolliffe E; Fu V; Lanford J; Weatherall M; Rosemergy I
Intern Med J; 2016 Oct; 46(10):1166-1171. PubMed ID: 27501863
[TBL] [Abstract][Full Text] [Related]
14. CHA
Mlodawska E; Tomaszuk-Kazberuk A; Lopatowska P; Kaminski M; Musial WJ
Intern Med J; 2017 Mar; 47(3):275-279. PubMed ID: 27860070
[TBL] [Abstract][Full Text] [Related]
15. Risk of ischemic stroke and utility of CHA
Tomasdottir M; Friberg L; Hijazi Z; Lindbäck J; Oldgren J
Clin Cardiol; 2019 Oct; 42(10):1003-1009. PubMed ID: 31490011
[TBL] [Abstract][Full Text] [Related]
16. Use of preoperative CHA2 DS2 -VASc score to predict the risk of atrial fibrillation after cardiothoracic surgery: a nested case-control study from the Atrial Fibrillation Suppression Trials (AFIST) I, II, and III.
Baker WL; Coleman CI; White CM; Kluger J
Pharmacotherapy; 2013 May; 33(5):489-95. PubMed ID: 23649811
[TBL] [Abstract][Full Text] [Related]
17. Heart failure: a weak link in CHA
Friberg L; Lund LH
ESC Heart Fail; 2018 Jun; 5(3):231-239. PubMed ID: 29446254
[TBL] [Abstract][Full Text] [Related]
18. Predictors of stroke or systemic embolism in patients with non-valvular atrial fibrillation with CHA
Choi H; Bae MH; Park YJ; Park HK; Lee E; Kim MS; Park JS; Kim HJ; Park BE; Kim HN; Kim N; Lee JH; Jang SY; Yang DH; Park HS; Cho Y
Ann Noninvasive Electrocardiol; 2023 Mar; 28(2):e13036. PubMed ID: 36625408
[TBL] [Abstract][Full Text] [Related]
19. CHA
Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of neutrophil-to-lymphocyte ratio for atrial fibrillation and stroke in type 2 diabetes mellitus: The Hong Kong Diabetes Study.
Chang C; Zhou J; Chou OHI; Chan J; Leung KSK; Lee TTL; Wong WT; Wai AKC; Liu T; Zhang Q; Lee S; Tse G
Endocrinol Diabetes Metab; 2023 Jan; 6(1):e397. PubMed ID: 36464326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
